Lingyin assists the firm in biotechnology patent prosecution. She has extensive knowledge in the areas of immunology, miRNA biology, pulmonary diseases and translational research.

Prior to joining Wolf Greenfield, Lingyin was a project scientist Cedars-Sinai Medical Center. She conducted research on pulmonary fibrosis and lung injury. Lingyin also interned in the tech transfer office at Cedars-Sinai where she evaluated patentability and marketability of disclosed therapeutic and medical device inventions and assisted external legal counsel in drafting patent applications and office action responses.

Lingyin received her PhD from Stony Brook University. Her research focused on DBP-Actin complex serves as Danger Associated Molecular Pattern (DAMPs) to induce acute lung injury in sepsis and trauma patients.


  • Parimon T, Brauer R, Schlesinger SY, Xie T, Jiang D, Ge L, Huang Y, Birkland T, Parks WC, Habiel D, Hogaboam C, Gharib SA, Deng N, Liu Z, Chen P. Am J Pathol. 2018 Jan 31.
  • Ge L, Habiel DM, Hansbro PM, Kim RY, Gharib SA, Edelman JD, Konigshoff M, Parimon T, Brauer R, Huang Y, Allen J, Jiang D, Kurkciyan AA, Mizuno T, Stripp BR, Noble PW, Hogaboam CM, Chen P. JCI Insight. 2016 Dec  8.
  • Brauer R, Ge L, Schlesinger SY, Birkland TP, Huang Y, Parimon T, Lee V,  McKinney BL, McGuire JK, Parks WC, Chen P. Am J Respir Crit Care Med. 2016 Aug 1.
  • Gharib SA, Edelman JD, Ge L, Chen P. Transplant Direct. 2015 Nov;1(10).
  • Kirillov V, Siler JT, Ramadass M, Ge L, Davis J, Grant G, Nathan SD, Jarai G, Trujillo  G. Am J Pathol. 2015 Apr.
  • Ge L, Trujillo G, Miller EJ, Kew RR. Immunobiology. 2014 Mar.
  • Trujillo G, Habiel DM, Ge L, Ramadass M, Cooke NE, Kew RR. J Immunol. 2013 Jul 15.
  • Trujillo G, Zhang J, Habiel DM, Ge L, Ramadass M, Ghebrehiwet B, Kew RR. Mol Immunol. 2011 Dec.


Expand All
Lingyin assists the firm in biotechnology patent prosecution. She has extensive knowledge in the areas of immunology, miRNA biology, pulmonary diseases and translational research.

Prior to joining Wolf Greenfield, Lingyin was a project scientist Cedars-Sinai Medical Center. She conducted research on pulmonary fibrosis and lung injury. Lingyin also interned in the tech transfer office at Cedars-Sinai where she evaluated patentability and marketability of disclosed therapeutic and medical device inventions and assisted external legal counsel in drafting patent applications and office action responses.

Lingyin received her PhD from Stony Brook University. Her research focused on DBP-Actin complex serves as Danger Associated Molecular Pattern (DAMPs) to induce acute lung injury in sepsis and trauma patients.
  • Parimon T, Brauer R, Schlesinger SY, Xie T, Jiang D, Ge L, Huang Y, Birkland T, Parks WC, Habiel D, Hogaboam C, Gharib SA, Deng N, Liu Z, Chen P. Am J Pathol. 2018 Jan 31.
  • Ge L, Habiel DM, Hansbro PM, Kim RY, Gharib SA, Edelman JD, Konigshoff M, Parimon T, Brauer R, Huang Y, Allen J, Jiang D, Kurkciyan AA, Mizuno T, Stripp BR, Noble PW, Hogaboam CM, Chen P. JCI Insight. 2016 Dec  8.
  • Brauer R, Ge L, Schlesinger SY, Birkland TP, Huang Y, Parimon T, Lee V,  McKinney BL, McGuire JK, Parks WC, Chen P. Am J Respir Crit Care Med. 2016 Aug 1.
  • Gharib SA, Edelman JD, Ge L, Chen P. Transplant Direct. 2015 Nov;1(10).
  • Kirillov V, Siler JT, Ramadass M, Ge L, Davis J, Grant G, Nathan SD, Jarai G, Trujillo  G. Am J Pathol. 2015 Apr.
  • Ge L, Trujillo G, Miller EJ, Kew RR. Immunobiology. 2014 Mar.
  • Trujillo G, Habiel DM, Ge L, Ramadass M, Cooke NE, Kew RR. J Immunol. 2013 Jul 15.
  • Trujillo G, Zhang J, Habiel DM, Ge L, Ramadass M, Ghebrehiwet B, Kew RR. Mol Immunol. 2011 Dec.